Axon Enterprise Appoints New CFO, Joshua Mann
Ticker: AXON · Form: 8-K · Filed: Mar 5, 2024 · CIK: 1069183
Sentiment: neutral
Topics: executive-appointment, compensation, cfo
TL;DR
Axon Enterprise names Joshua Mann new CFO, starting March 11th with $400k salary + stock.
AI Summary
Axon Enterprise, Inc. announced on March 4, 2024, the appointment of Joshua L. Mann as its new Chief Financial Officer, effective March 11, 2024. Mann will receive an annual base salary of $400,000 and is eligible for a discretionary annual bonus. He will also be granted 15,000 restricted stock units, vesting over three years.
Why It Matters
The appointment of a new CFO is a significant leadership change that can impact financial strategy and investor confidence.
Risk Assessment
Risk Level: low — This filing primarily concerns a routine executive appointment and compensation, with no immediate financial distress or significant operational changes indicated.
Key Numbers
- $400,000 — CFO Base Salary (Annual compensation for Joshua L. Mann.)
- 15,000 — RSUs Granted (Stock units awarded to the new CFO, vesting over three years.)
Key Players & Entities
- Axon Enterprise, Inc. (company) — Registrant
- Joshua L. Mann (person) — Appointed Chief Financial Officer
- $400,000 (dollar_amount) — Annual base salary for new CFO
- 15,000 (dollar_amount) — Restricted stock units granted to new CFO
- March 11, 2024 (date) — Effective date of CFO appointment
FAQ
Who is the new Chief Financial Officer of Axon Enterprise, Inc.?
Joshua L. Mann has been appointed as the new Chief Financial Officer of Axon Enterprise, Inc.
When does Joshua L. Mann's appointment as CFO become effective?
The appointment of Joshua L. Mann as CFO is effective March 11, 2024.
What is the annual base salary for the new CFO?
The annual base salary for Joshua L. Mann is $400,000.
What equity compensation is the new CFO receiving?
Joshua L. Mann will be granted 15,000 restricted stock units, which will vest over a three-year period.
What was Axon Enterprise's former company name?
Axon Enterprise, Inc.'s former company name was TASER INTERNATIONAL INC, with a name change date of February 12, 2001.
Filing Stats: 438 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2024-03-05 16:42:37
Key Financial Figures
- $0.00001 — ange on which registered Common Stock, $0.00001 Par Value AXON The Nasdaq Global Se
Filing Documents
- axon-20240304x8k.htm (8-K) — 36KB
- 0001069183-24-000015.txt ( ) — 165KB
- axon-20240304.xsd (EX-101.SCH) — 4KB
- axon-20240304_def.xml (EX-101.DEF) — 3KB
- axon-20240304_lab.xml (EX-101.LAB) — 21KB
- axon-20240304_pre.xml (EX-101.PRE) — 12KB
- axon-20240304x8k_htm.xml (XML) — 5KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 4, 2024 Date of Report (Date of earliest event reported) Axon Enterprise, Inc. (Exact name of registrant as specified in its charter) Delaware 001-16391 86-0741227 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 17800 N. 85 th St. Scottsdale , Arizona 85255 (Address of principal executive offices, including zip code) ( 480 ) 991-0797 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.00001 Par Value AXON The Nasdaq Global Select Market Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers ; Compensatory Arrangements of Certain Officers. On March 4, 2024, the Board of Directors (the "Board") of Axon Enterprise, Inc. (the "Company") accepted Mark W. Kroll, Ph.D.'s resignation from the Board, effective as of the date of the Company's 2024 Annual Meeting of Shareholders. The Board greatly appreciates Dr. Kroll's deep commitment, leadership and many contributions to the Board and to the Company's growth and progress during his years of service. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 5, 2024 Axon Enterprise, Inc. By: /s/ Isaiah Fields Isaiah Fields Chief Legal Officer and Corporate Secretary